Physician profile
Selina Lin
NPI 1093793630
$4,404.36
in general payments reported to CMS, 2019-2025
36 companies · $407 in 2025
The $407 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2020: $489 · 2021: $759 · 2022: $699 · 2023: $741 · 2024: $578 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639 · Education: $86.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,639.15 |
| Education | $86.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $666.31 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $438.26 | 2023-2025 | Myfembree |
| Pfizer INC. | $427.41 | 2019-2024 | |
| Exeltis, USA INC. | $284.76 | 2019-2024 | Slynd |
| Caldera Medical, INC | $273.07 | 2019-2023 | Desara |
| Evofem Biosciences, INC. | $255.68 | 2021-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $194.96 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $190.16 | 2019-2023 | |
| Therapeuticsmd, INC. | $160.16 | 2019-2022 | |
| Astellas Pharma US INC | $160.10 | 2023-2024 | Veozah |
| Acessa Health INC. | $139.98 | 2019-2022 | |
| Myovant Sciences INC. | $130.69 | 2021-2022 | |
| Sage Therapeutics, LLC | $112.57 | 2024-2025 | Zurzuvae |
| Avion Pharmaceuticals | $102.62 | 2020-2023 | Balcoltra |
| Merck Sharp & Dohme LLC | $89.58 | 2020-2023 | Gardasil 9 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $82.93 | 2024-2025 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $78.32 | 2019-2020 | |
| Allergan, INC. | $65.03 | 2019-2020 | |
| Baxter Healthcare | $47.83 | 2024 | Perclot |
| Cumberland Pharmaceuticals, INC. | $46.16 | 2023-2024 | Kristalose |
| Amgen INC. | $45.44 | 2019-2025 | Evenity, Prolia |
| Hologic Sales and Service, LLC | $42.95 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $41.61 | 2021-2022 | |
| Lupin INC. | $40.20 | 2019-2020 | |
| Organon LLC | $35.26 | 2022-2024 | |
| Millicent US INC | $34.96 | 2024-2025 | Intrarosa, Femring |
| Supernus Pharmaceuticals, INC. | $34.58 | 2025 | Qelbree |
| Teva Pharmaceuticals USA, INC. | $32.91 | 2021 | |
| Renovia INC | $31.53 | 2019-2020 | |
| Shield Therapeutics INC | $27.54 | 2022-2023 | Accrufer |
| Coopersurgical, INC. | $21.19 | 2025 | Paragard T 380a |
| Biom'Up Sa | $16.26 | 2019 | |
| Biom'Up France Sas | $15.59 | 2020 | |
| Medicem INC. | $13.01 | 2020 | |
| Convatec INC. | $12.89 | 2022 | |
| Agile Therapeutics, INC. | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selina Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.